Importantly, sustained improvement in alanine aminotransferase (ALT) and aspartate aminotransferase (AST), together with improvement in hepatic steatosis, is a hallmark of reduced risk of progression to cirrhosis among NAFLD patients.24, 25, 50, 51, 52, 53. The gene discussed is GPT; the disease is Cirrhosis.